HRP20060403A2 - Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders - Google Patents
Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disordersInfo
- Publication number
- HRP20060403A2 HRP20060403A2 HR20060403A HRP20060403A HRP20060403A2 HR P20060403 A2 HRP20060403 A2 HR P20060403A2 HR 20060403 A HR20060403 A HR 20060403A HR P20060403 A HRP20060403 A HR P20060403A HR P20060403 A2 HRP20060403 A2 HR P20060403A2
- Authority
- HR
- Croatia
- Prior art keywords
- disorders
- derivatives
- treatment
- central nervous
- indol
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- 150000005625 indol-2-ones Chemical class 0.000 title 1
- -1 3,3-disubstituted indol-2-one Chemical class 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000005095 gastrointestinal system Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400955A HU0400955D0 (en) | 2004-05-11 | 2004-05-11 | Pyridine derivatives of dialkyl oxindoles |
| HU0500463A HUP0500463A3 (en) | 2005-05-05 | 2005-05-05 | Pyridine derivatives of dialkyl-oxindoles |
| PCT/HU2005/000051 WO2005108390A1 (en) | 2004-05-11 | 2005-05-11 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20060403A2 true HRP20060403A2 (en) | 2007-04-30 |
Family
ID=89985998
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20060403A HRP20060403A2 (en) | 2004-05-11 | 2006-11-20 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
| HR20080129T HRP20080129T3 (en) | 2004-05-11 | 2008-03-20 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080129T HRP20080129T3 (en) | 2004-05-11 | 2008-03-20 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070232662A1 (pt) |
| EP (1) | EP1751138B9 (pt) |
| JP (1) | JP2007537228A (pt) |
| KR (1) | KR20070014189A (pt) |
| AT (1) | ATE382045T1 (pt) |
| AU (1) | AU2005240844A1 (pt) |
| BG (1) | BG109770A (pt) |
| CA (1) | CA2566426A1 (pt) |
| CZ (1) | CZ2006772A3 (pt) |
| DE (1) | DE602005004024T2 (pt) |
| EA (1) | EA010865B1 (pt) |
| ES (1) | ES2299033T3 (pt) |
| HR (2) | HRP20060403A2 (pt) |
| IL (1) | IL179030A0 (pt) |
| MX (1) | MXPA06013065A (pt) |
| NO (1) | NO20065661L (pt) |
| PL (2) | PL381614A1 (pt) |
| PT (1) | PT1751138E (pt) |
| RS (1) | RS20060622A (pt) |
| SK (1) | SK51062006A3 (pt) |
| WO (1) | WO2005108390A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070011552A (ko) * | 2004-05-11 | 2007-01-24 | 에지스 지오기스제르기아르 엔와이알티. | ５-ｈｔ７ 수용체 활성제로서 알킬 옥스인돌의 피리딘유도체 |
| ES2329388T3 (es) | 2004-05-11 | 2009-11-25 | Egis Gyogyszergyar Nyrt | Derivados de 3-(((4-fenil)-piperazin-1-il)-alquil)-3-alquil-1,3-dihidro-2h-indol-2-ona y los compuestos correspondientes para el tratamiento de los trastornos del sistema nervioso central. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| CN1168716C (zh) * | 1998-04-22 | 2004-09-29 | 明治制果株式会社 | 光学活性四氢苯并吲哚衍生物 |
| FR2779429B1 (fr) * | 1998-06-03 | 2000-07-13 | Synthelabo | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
| AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
-
2005
- 2005-05-11 DE DE602005004024T patent/DE602005004024T2/de not_active Expired - Fee Related
- 2005-05-11 US US11/596,471 patent/US20070232662A1/en not_active Abandoned
- 2005-05-11 EP EP05745439A patent/EP1751138B9/en active Active
- 2005-05-11 JP JP2007512358A patent/JP2007537228A/ja active Pending
- 2005-05-11 KR KR1020067025313A patent/KR20070014189A/ko not_active Application Discontinuation
- 2005-05-11 RS RSP-2006/0622A patent/RS20060622A/sr unknown
- 2005-05-11 CA CA002566426A patent/CA2566426A1/en not_active Abandoned
- 2005-05-11 PT PT05745439T patent/PT1751138E/pt unknown
- 2005-05-11 SK SK5106-2006A patent/SK51062006A3/sk not_active Application Discontinuation
- 2005-05-11 ES ES05745439T patent/ES2299033T3/es active Active
- 2005-05-11 WO PCT/HU2005/000051 patent/WO2005108390A1/en active IP Right Grant
- 2005-05-11 EA EA200602082A patent/EA010865B1/ru not_active IP Right Cessation
- 2005-05-11 AT AT05745439T patent/ATE382045T1/de not_active IP Right Cessation
- 2005-05-11 MX MXPA06013065A patent/MXPA06013065A/es active IP Right Grant
- 2005-05-11 AU AU2005240844A patent/AU2005240844A1/en not_active Abandoned
- 2005-05-11 CZ CZ20060772A patent/CZ2006772A3/cs unknown
- 2005-05-11 PL PL381614A patent/PL381614A1/pl not_active Application Discontinuation
- 2005-05-11 PL PL05745439T patent/PL1751138T3/pl unknown
-
2006
- 2006-11-02 IL IL179030A patent/IL179030A0/en unknown
- 2006-11-20 HR HR20060403A patent/HRP20060403A2/xx not_active Application Discontinuation
- 2006-12-06 NO NO20065661A patent/NO20065661L/no not_active Application Discontinuation
- 2006-12-11 BG BG109770A patent/BG109770A/bg unknown
-
2008
- 2008-03-20 HR HR20080129T patent/HRP20080129T3/xx unknown
-
2009
- 2009-07-09 US US12/500,335 patent/US20090281137A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090281137A1 (en) | 2009-11-12 |
| DE602005004024T2 (de) | 2008-12-24 |
| JP2007537228A (ja) | 2007-12-20 |
| IL179030A0 (en) | 2007-03-08 |
| EA010865B1 (ru) | 2008-12-30 |
| AU2005240844A1 (en) | 2005-11-17 |
| DE602005004024D1 (de) | 2008-02-07 |
| PL381614A1 (pl) | 2007-06-11 |
| BG109770A (bg) | 2008-05-30 |
| EP1751138B9 (en) | 2008-11-12 |
| CZ2006772A3 (cs) | 2007-03-14 |
| EP1751138B1 (en) | 2007-12-26 |
| RS20060622A (en) | 2008-06-05 |
| EP1751138A1 (en) | 2007-02-14 |
| HRP20080129T3 (en) | 2008-04-30 |
| CA2566426A1 (en) | 2005-11-17 |
| US20070232662A1 (en) | 2007-10-04 |
| KR20070014189A (ko) | 2007-01-31 |
| PT1751138E (pt) | 2008-02-25 |
| EA200602082A1 (ru) | 2007-04-27 |
| NO20065661L (no) | 2007-02-08 |
| MXPA06013065A (es) | 2007-05-04 |
| PL1751138T3 (pl) | 2008-05-30 |
| SK51062006A3 (sk) | 2007-04-05 |
| ATE382045T1 (de) | 2008-01-15 |
| WO2005108390A1 (en) | 2005-11-17 |
| ES2299033T3 (es) | 2008-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0303180D0 (sv) | Novel compounds | |
| SE0203713D0 (sv) | Novel compounds | |
| CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
| NO20082508L (no) | Aminopyrimidiner anvendelige som kinaseinhibitorer | |
| MY143367A (en) | Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases | |
| NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
| MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| SE0201635D0 (sv) | Novel compounds | |
| MX2007011847A (es) | Derivados de pirimidindiona como antagonistas del receptor de procineticina 2. | |
| MY153719A (en) | Prokineticin 1 receptor antagonists | |
| NO20084489L (no) | Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet | |
| EA200601462A1 (ru) | Соединения для лечения заболеваний | |
| EA201000550A1 (ru) | Производные тиазола | |
| MX2007011698A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| NO20076515L (no) | Hydantoinforbindelser | |
| GB0524814D0 (en) | Compounds | |
| JO2747B1 (en) | Vehicles | |
| GB0519760D0 (en) | Novel compounds | |
| ATE524463T1 (de) | 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung | |
| HRP20060402A2 (en) | Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents | |
| MX2007009108A (es) | Derivados de imidazol. | |
| HRP20060404A2 (en) | New piperazine derivatives of dialkyl oxindoles | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| HRP20060403A2 (en) | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders | |
| HRP20060420A2 (en) | Piperazine derivatives of alkyl oxindoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090504 Year of fee payment: 5 |
|
| OBST | Application withdrawn |